The future of next generation TKIs looks promising with ongoing research focused on: - Combination Therapies: Combining TKIs with other treatments like immunotherapy to enhance efficacy. - Biomarker Development: Identifying biomarkers to predict response and resistance, allowing for more personalized treatment plans. - Novel Targets: Exploring new targets and pathways to overcome resistance and treat a broader range of cancers.
